Cardiometabolic & Hypertension Research
Hypertension Clinical Research
Hypertension affects millions of people worldwide and significantly increases the risk of heart disease, stroke, kidney disease, and other serious health conditions. CenExel partners with sponsors to advance innovative hypertension therapies through expert-led clinical trials focused on improving cardiovascular outcomes and patient quality of life.
Advancing Hypertension & Cardiovascular Research
CenExel provides specialized clinical research expertise in hypertension and cardiovascular medicine. Our experienced investigators and operational teams support Phase I–IV trials with a focus on patient recruitment, biomarker analysis, and efficient trial execution.
Improve Cardiovascular Outcomes
Accelerate Clinical Development
Hypertension Conditions We Research
Our cardiovascular research sites support a broad range of hypertension-related indications and associated metabolic and cardiac disorders.
- Essential Hypertension
- Resistant Hypertension
- Pulmonary Hypertension
- Secondary Hypertension
- Hypertensive Heart Disease
- Chronic Kidney Disease with Hypertension
- Heart Failure & Hypertension
- Cardiometabolic Disorders
Why Sponsors Choose CenExel for Hypertension Research
Our cardiovascular research teams deliver scientific expertise, diverse patient access, and operational excellence to support successful hypertension clinical programs.
01
Cardiovascular Expertise
Experienced investigators specializing in hypertension, heart failure, and cardiometabolic disease research.
02
Biomarker & Endpoint Support
Advanced cardiovascular biomarkers and clinical endpoint strategies to support accurate trial outcomes.
03
Diverse Patient Populations
Access to broad and diverse patient communities across multiple U.S. research sites.
04
Accelerated Enrollment
Proven recruitment strategies designed to improve enrollment speed and retention rates.
Supported Hypertension Trial Phases
CenExel supports early and late-phase hypertension research programs from first-in-human studies through large multicenter Phase IV trials.
Active across all phases
- Phase I
- Phase II
- Phase III
- Phase IV
Hypertension Task Force
CenExel supports hypertension and cardiovascular research across diverse patient populations with experienced investigators, centralized recruitment strategies, and high-performing research sites.






